RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.502
EU - Europa 17.256
AS - Asia 14.892
SA - Sud America 2.037
AF - Africa 357
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 24
Totale 67.118
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.987
GB - Regno Unito 4.996
IT - Italia 4.455
SG - Singapore 4.121
CN - Cina 4.103
SE - Svezia 3.137
HK - Hong Kong 1.852
BR - Brasile 1.551
VN - Vietnam 1.528
DE - Germania 951
BD - Bangladesh 687
UA - Ucraina 654
TR - Turchia 650
RU - Federazione Russa 639
FI - Finlandia 606
FR - Francia 564
KR - Corea 491
IN - India 372
CA - Canada 247
BG - Bulgaria 245
NL - Olanda 191
ID - Indonesia 173
AR - Argentina 154
IQ - Iraq 136
MX - Messico 133
JP - Giappone 125
IE - Irlanda 118
ZA - Sudafrica 112
ES - Italia 108
RO - Romania 91
PK - Pakistan 89
BE - Belgio 85
PL - Polonia 83
EC - Ecuador 78
AE - Emirati Arabi Uniti 75
CO - Colombia 72
LT - Lituania 62
VE - Venezuela 50
CH - Svizzera 49
MY - Malesia 49
EG - Egitto 47
IR - Iran 45
AU - Australia 41
CL - Cile 41
MA - Marocco 41
PH - Filippine 40
PY - Paraguay 37
UZ - Uzbekistan 37
CZ - Repubblica Ceca 32
JO - Giordania 31
AT - Austria 30
IL - Israele 30
TN - Tunisia 30
SA - Arabia Saudita 29
DZ - Algeria 28
TH - Thailandia 28
JM - Giamaica 27
NP - Nepal 25
PT - Portogallo 24
GR - Grecia 23
KE - Kenya 22
TW - Taiwan 22
CR - Costa Rica 20
UY - Uruguay 19
AZ - Azerbaigian 17
ET - Etiopia 17
KZ - Kazakistan 17
PE - Perù 17
EU - Europa 16
BO - Bolivia 15
SN - Senegal 15
DK - Danimarca 14
KG - Kirghizistan 14
TT - Trinidad e Tobago 14
BY - Bielorussia 13
DO - Repubblica Dominicana 13
LB - Libano 13
RS - Serbia 13
AL - Albania 12
HU - Ungheria 12
HN - Honduras 10
PR - Porto Rico 10
NZ - Nuova Zelanda 9
OM - Oman 9
PA - Panama 9
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
QA - Qatar 8
CY - Cipro 7
HR - Croazia 7
LK - Sri Lanka 7
NI - Nicaragua 7
NO - Norvegia 7
AM - Armenia 6
EE - Estonia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
MN - Mongolia 6
NG - Nigeria 6
Totale 67.000
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Ashburn 2.978
Santa Clara 2.868
Singapore 2.506
Fairfield 2.350
Hong Kong 1.820
Stockholm 1.818
Chandler 1.757
Woodbridge 1.635
Hefei 1.336
Chicago 1.299
Jacksonville 1.265
Houston 1.096
San Jose 1.093
Seattle 999
Wilmington 992
Dearborn 954
Ann Arbor 918
Beijing 819
Cambridge 798
Los Angeles 791
Nyköping 775
London 634
Modena 542
Council Bluffs 512
Ho Chi Minh City 499
Seoul 431
Salt Lake City 386
The Dalles 386
New York 374
Izmir 359
Helsinki 355
Hanoi 340
Milan 302
Dallas 265
Princeton 249
Sofia 234
Eugene 220
San Diego 214
Lauterbourg 203
Rome 196
Buffalo 195
Tampa 180
Moscow 168
Bologna 167
Elk Grove Village 163
São Paulo 143
Shanghai 142
Munich 126
Des Moines 119
Orem 119
Jakarta 116
Redwood City 112
Frankfurt am Main 107
Lancaster 106
Tokyo 97
Bremen 94
Dublin 94
Fremont 90
Falls Church 88
Phoenix 86
Naples 83
Miami 77
Columbus 76
Brussels 73
Reggio Emilia 73
Chennai 69
Sterling 69
Boardman 64
Florence 62
Da Nang 59
Guangzhou 59
Haiphong 59
Toronto 57
Dulles 54
Johannesburg 54
Warsaw 54
Montreal 53
Parma 53
Turin 53
Catania 52
Amsterdam 51
Brooklyn 50
Baghdad 49
Detroit 47
Atlanta 46
Nanjing 44
Bari 43
Como 42
Mexico City 41
Denver 40
Norwalk 38
Kent 37
Rio de Janeiro 37
Washington 37
Boston 35
Kansas City 35
Miano 35
Palermo 33
Tulare 33
Totale 45.923
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.041
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 597
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 512
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 495
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 478
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 467
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 464
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 459
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 449
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 433
Cationic liposomes for gene transfection 424
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 422
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 421
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 419
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 417
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 408
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 404
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 400
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 397
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 394
Amphiphilic ion pairs of tobramycin with lipoamino acids 389
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 388
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 380
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 380
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 376
Polymeric nanoparticles for the drug delivery to the central nervous system 374
Nanoparticle transport across the blood brain barrier 370
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 369
Vegetable cells in Papanicolaou-stained cervical smears 368
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 366
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 366
Nanomedicine: the future for advancing medicine and neuroscience 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 363
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 363
Brain targeting with polymeric nanoparticles: which administration route should we take? 361
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 360
Protein corona and nanoparticles: How can we investigate on? 356
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 350
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 347
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 346
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 342
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 341
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 337
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 336
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 334
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 333
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 333
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 333
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 332
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 332
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 332
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 332
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 332
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 330
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 328
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 325
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 324
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 323
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 322
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 321
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 319
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 318
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 317
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 316
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 316
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 316
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 313
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 313
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 311
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 309
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 309
Functionalization of liposomes: microscopical methods for preformulative screening 309
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 307
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 307
Colloidal systems for CNS drug delivery 306
PLA/PLGA nanoparticles for sustained release of docetaxel 306
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 304
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 299
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 297
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 295
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 291
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 288
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 285
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 283
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 281
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 278
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 276
Brain targeting by engineered nanoparticles 275
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 272
Ketorolac tromethamine liposomes: Encapsulation and release studies 272
Totale 37.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 252.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 252.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202623.708 1.329 851 1.566 2.785 4.348 1.379 2.238 1.032 3.875 1.985 1.172 1.148
2026/2027426 426 0 0 0 0 0 0 0 0 0 0 0
Totale 67.529